Clinical, histologic, and molecular analysis of differences between erythematotelangiectatic rosacea and telangiectatic photoaging

JAMA Dermatology

Volumn 151, Issue 8, 2015, Pages 825-836

  Helfrich, Yolanda R ^a   Maier, Lisa E ^a   Cui, Yilei ^a   Fisher, Gary J ^a   Chubb, Heather ^a   Fligiel, Suzanne ^a   Sachs, Dana ^a   Varani, James ^a   Voorhees, John ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; CALCITONIN GENE RELATED PEPTIDE; CHEMOKINE RECEPTOR CXCR4; COLLAGEN TYPE 1; COLLAGEN TYPE 3; GELATINASE B; INTERSTITIAL COLLAGENASE; MESSENGER RNA; STROMAL CELL DERIVED FACTOR 1; STROMELYSIN; SUBSTANCE P; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; CASE CONTROL STUDY; CELL ACTIVATION; CELL COUNT; CGRP ALPHA GENE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIFFERENTIAL DIAGNOSIS; ELASTOSIS; ELECTRON MICROSCOPY; ERYTHEMATOTELANGIECTATIC ROSACEA; FACE ERYTHEMA; FEMALE; GENE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; MALE; MAST CELL; MATRIX METALLOPROTEINASE 3 GENE; MIDDLE AGED; MOLECULAR DIAGNOSIS; OBSERVATIONAL STUDY; PHOTOAGING; POIKILODERMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROSACEA; SKIN ATROPHY; SKIN BIOPSY; SUBSTANCE P GENE; TELANGIECTASIA; TELANGIECTATIC PHOTOAGING; AGED; CUTANEOUS PARAMETERS; ERYTHEMA; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; TELANGIECTASIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; ERYTHEMA; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROSACEA; SKIN AGING; TELANGIECTASIS;

EID: 84941629123     PISSN: 21686068     EISSN: 21686084     Source Type: Journal    
DOI: 10.1001/jamadermatol.2014.4728     Document Type: Article

References (34)

1. Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol. 2002;46(4):584-587.
2. Danby FW. Rosacea, acne rosacea, and actinic telangiectasia. J Am Acad Dermatol. 2005;52(3, pt 1):539-540.
3. Powell FC. Clinical practice: rosacea. N Engl J Med. 2005;352(8):793-803.
4. Wilkin J, Dahl M, Detmar M, et al; National Rosacea Society Expert Committee. Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol. 2004;50(6):907-912.
5. Griffiths CE, Wang TS, Hamilton TA, Voorhees JJ, Ellis CN. A photonumeric scale for the assessment of cutaneous photodamage. Arch Dermatol. 1992; 128(3):347-351.
6. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 1988;124(6):869-871.
7. Fligiel SE, Varani J, Datta SC, Kang S, Fisher GJ, Voorhees JJ. Collagen degradation in aged/photodamaged skin in vivo and after exposure to matrix metalloproteinase-1 in vitro. J Invest Dermatol. 2003;120(5):842-848.
8. Varani J, Spearman D, Perone P, et al. Inhibition of type I procollagen synthesis by damaged collagen in photoaged skin and by collagenase-degraded collagen in vitro. Am J Pathol. 2001;158(3):931-942.
9. Kang S, Cho S, Chung JH, Hammerberg C, Fisher GJ, Voorhees JJ. Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-kappaB and activator protein-1 in inflammatory acne lesions in vivo. Am J Pathol. 2005;166(6):1691-1699.
10. Quan T, He T, Kang S, Voorhees JJ, Fisher GJ. Ultraviolet irradiation alters transforming growth factor beta/smad pathway in human skin in vivo. J Invest Dermatol. 2002;119(2):499-506.
11. Aroni K, Tsagroni E, Kavantzas N, Patsouris E, Ioannidis E. A study of the pathogenesis of rosacea: how angiogenesis and mast cells may participate in a complex multifactorial process. Arch Dermatol Res. 2008;300(3):125-131.
12. Schwab VD, Sulk M, Seeliger S, et al. Neurovascular and neuroimmune aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc. 2011;15(1):53-62.
13. Samoszuk M, Kanakubo E, Chan JK. Degranulating mast cells in fibrotic regions of human tumors and evidence that mast cell heparin interferes with the growth of tumor cells through a mechanism involving fibroblasts. BMC Cancer. 2005;5:121.
14. Yamasaki K, Di Nardo A, Bardan A, et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med. 2007;13(8):975-980.
15. Leyden JJ. Clinical features of ageing skin. Br J Dermatol. 1990;122(suppl 35):1-3.
16. Gilchrest BA. Skin aging and photoaging: an overview. J Am Acad Dermatol. 1989;21(3, pt 2): 610-613.
17. Varani J, Perone P, Warner RL, et al. Vascular tube formation on matrix metalloproteinase-1-damaged collagen. Br J Cancer. 2008;98(10):1646-1652.
18. Bamford JT. Rosacea: current thoughts on origin. Semin Cutan Med Surg. 2001;20(3):199-206.
19. Millikan LE. Rosacea as an inflammatory disorder: a unifying theory? Cutis. 2004;73(1) (suppl):5-8.
20. Lee E, Granstein RD. Neuroimmunology. In: Gaspari AA, Tyring SK, eds. Clinical and Basic Immunodermatology. London, England: Springer; 2008:31-44.
21. Lonne-Rahm S, Nordlind K, Edstrom DW, Ros AM, Berg M. Laser treatment of rosacea: a pathoetiological study. Arch Dermatol. 2004;140 (11):1345-1349.
22. Kürkçüoʇlu N, Alaybeyi F. Substance P immunoreactivity in rosacea. J Am Acad Dermatol. 1991;25(4):725-726.
23. Powell FC, Corbally N, Powell D. Substance P and rosacea. J Am Acad Dermatol. 1993;28(1):132-133.
24. Brain SD, Grant AD. Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev. 2004;84(3):903-934.
25. Hou Q, Barr T, Gee L, et al. Keratinocyte expression of calcitonin gene-related peptide β: implications for neuropathic and inflammatory pain mechanisms. Pain. 2011;152(9):2036-2051.
26. Aubdool AA, Brain SD. Neurovascular aspects of skin neurogenic inflammation. J Investig Dermatol Symp Proc. 2011;15(1):33-39.
27. Steinhoff M, Buddenkotte J, Aubert J, et al. Clinical, cellular, and molecular aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc. 2011;15(1):2-11.
28. Kulka M, Sheen CH, Tancowny BP, Grammer LC, Schleimer RP. Neuropeptides activate human mast cell degranulation and chemokine production. Immunology. 2008;123(3):398-410.
29. Brain SD, Cox HM. Neuropeptides and their receptors: innovative science providing novel therapeutic targets. Br J Pharmacol. 2006;147(suppl 1):S202-S211.
30. Juremalm M, Hjertson M, Olsson N, Harvima I, Nilsson K, Nilsson G. The chemokine receptor CXCR4 is expressed within the mast cell lineage and its ligand stromal cell-derived factor-1alpha acts as a mast cell chemotaxin. Eur J Immunol. 2000;30(12): 3614-3622.
31. Grice EA, Kong HH, Conlan S, et al; NISC Comparative Sequencing Program. Topographical and temporal diversity of the human skin microbiome. Science. 2009;324(5931):1190-1192.
32. Grice EA, Segre JA. The skinmicrobiome. Nat Rev Microbiol. 2011;9(4):244-253.
33. Lai Y, Cogen AL, Radek KA, et al. Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections. J Invest Dermatol. 2010;130(9):2211-2221.
34. Lai Y, Di Nardo A, Nakatsuji T, et al. Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nat Med. 2009;15 (12):1377-1382.